These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular modeling of hydration in drug design. Mancera RL Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853 [TBL] [Abstract][Full Text] [Related]
3. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development. Rajamani R; Good AC Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857 [TBL] [Abstract][Full Text] [Related]
4. The use of protein-ligand interaction fingerprints in docking. Brewerton SC Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089 [TBL] [Abstract][Full Text] [Related]
5. Informatics and modeling challenges in fragment-based drug discovery. Hubbard RE; Chen I; Davis B Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855 [TBL] [Abstract][Full Text] [Related]
6. Lead optimization via high-throughput molecular docking. Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852 [TBL] [Abstract][Full Text] [Related]
8. Physics-based scoring of protein-ligand interactions: explicit polarizability, quantum mechanics and free energies. Bryce RA Future Med Chem; 2011 Apr; 3(6):683-98. PubMed ID: 21554075 [TBL] [Abstract][Full Text] [Related]
9. Virtual high-throughput screening of molecular databases. Seifert MH; Kraus J; Kramer B Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856 [TBL] [Abstract][Full Text] [Related]
10. Contribution of conformer focusing to the uncertainty in predicting free energies for protein-ligand binding. Tirado-Rives J; Jorgensen WL J Med Chem; 2006 Oct; 49(20):5880-4. PubMed ID: 17004703 [TBL] [Abstract][Full Text] [Related]
11. Importance of molecular computer modeling in anticancer drug development. Geromichalos GD J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268 [TBL] [Abstract][Full Text] [Related]
12. Structure-based drug metabolism predictions for drug design. Sun H; Scott DO Chem Biol Drug Des; 2010 Jan; 75(1):3-17. PubMed ID: 19878193 [TBL] [Abstract][Full Text] [Related]
13. In silico identification of bioisosteric functional groups. Ertl P Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854 [TBL] [Abstract][Full Text] [Related]
14. E-novo: an automated workflow for efficient structure-based lead optimization. Pearce BC; Langley DR; Kang J; Huang H; Kulkarni A J Chem Inf Model; 2009 Jul; 49(7):1797-809. PubMed ID: 19552372 [TBL] [Abstract][Full Text] [Related]
15. Recent developments in de novo design and scaffold hopping. Mauser H; Guba W Curr Opin Drug Discov Devel; 2008 May; 11(3):365-74. PubMed ID: 18428090 [TBL] [Abstract][Full Text] [Related]
16. Pocket extraction on proteins via the Voronoi diagram of spheres. Kim D; Cho CH; Cho Y; Ryu J; Bhak J; Kim DS J Mol Graph Model; 2008 Apr; 26(7):1104-12. PubMed ID: 18023220 [TBL] [Abstract][Full Text] [Related]
17. Molecular optimization using computational multi-objective methods. Nicolaou CA; Brown N; Pattichis CS Curr Opin Drug Discov Devel; 2007 May; 10(3):316-24. PubMed ID: 17554858 [TBL] [Abstract][Full Text] [Related]
18. Electrostatics in proteins and protein-ligand complexes. Kukić P; Nielsen JE Future Med Chem; 2010 Apr; 2(4):647-66. PubMed ID: 21426012 [TBL] [Abstract][Full Text] [Related]
19. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors. Ferrari AM; Degliesposti G; Sgobba M; Rastelli G Bioorg Med Chem; 2007 Dec; 15(24):7865-77. PubMed ID: 17870536 [TBL] [Abstract][Full Text] [Related]
20. A semiempirical free energy force field with charge-based desolvation. Huey R; Morris GM; Olson AJ; Goodsell DS J Comput Chem; 2007 Apr; 28(6):1145-52. PubMed ID: 17274016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]